Familial hypertrophic cardiomyopathy: A paradigm of the cardiac hypertrophic response to injury

Annals of Medicine

Volumn 30, Issue SUPPL. 1, 1998, Pages 24-32

  Marian, Ali J ^a,b   Roberts, Robert ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MS SM 677 ^*  (United States)

Author keywords

Genetics; Hypertrophic cardiomyopathy; Hypertrophy; Mutations; Sarcomere

Indexed keywords

MUTANT PROTEIN; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN; TROPOMYOSIN; TROPONIN; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT INHERITANCE; CONFERENCE PAPER; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GENE MUTATION; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MUSCLE FIBRIL; PATHOGENESIS; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SARCOMERE; SUDDEN DEATH;

ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC; HEART INJURIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MICE; MUTATION; PEDIGREE; PROGNOSIS; SARCOMERES;

EID: 0031690161     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (74)

1. Marian AJ, Roberts R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 1995; 92: 1336-47.
2. Schwartz K, Carrier L, Cuicheney P, Komajda M. Molecular basis of familial cardiomyopathies. Circulation 1995; 91: 532-40.
3. Watkins H, Seidman JG, Seidman CE. Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum Mol Genet 1995; 4: 1721-7.
4. Ferrans VJ, Morrow AG, Roberts WC. Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis: a study of operatively excised left ventricular outflow tract muscle in 14 patients. Circulation 1972; 45: 769-92.
5. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 1996; 276: 199-204.
6. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4,111 subjects in the CARDIA study. Circulation 1995; 92: 785-9.
7. Savage DD, Castelli WP, Abbott RO, et al. Hypertrophic cardiomyopathy and its markers in the general population. The great masquerader revisited: The Framingham Study. J Cardiovasc Ultrasonogr 1983; 2: 41-7.
8. Al-Mahdawi S, Chamberlai S, Chojnosvska L, et al. The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene. Br Heart J 1994; 72: 105-11.
9. Charron P, Dubourg O, Desnos M, et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 1997; 96: 214-9.
10. Thierfelder L, Watkins H, MacRae C, et al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994; 77: 701-12.
11. Geisterfer-Lowrance AA, Kass S, Tanigawa G, et al. A molecular basis for familial hypertrophic cardiomyopathy: a betacardiac myosin heavy chain gene missense mutation. Cell 1990; 62: 999-1006.
12. Watkins H, Conner D, Thierfelder L, et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 1995; 11: 434-5.
13. Bonne G, Carrier L, Bercovici J, et al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 1995; 11: 438-9.
14. Poetter K, Jiang H, Hassenzadeh S, et al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 1996; 13: 63-9.
15. Kimua A, Harada H, Park J-E, et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 1997; 16: 379-82.
16. Liew CC, Sole MJ, Yamauchi-Takihara K, et al. Complete sequence and organization of the human cardiac b-myosin heavy chain gene. Nucleic Acids Res 1990; 18: 3647-51.
17. Swynghedauw B. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol Rev 1986; 3: 710-60.
18. Finer JT, Simmons RM, Spudich JA. Single myosin mechanics: picoNewton forces and nanometer steps. Nature 1994; 368: 113-9.
19. Ishijima A, Harada Y, Kojima H, Funatsu T, Higuchi H, Yanagida T. Single-molecule analysis of the actomyosin motor using nano-manipulation. Biochem Biophys Res Commun 1994; 199: 1057-63.
20. Watkins H, Thierfelder L, Anan R, et al. Independent origin of identical β cardiac myosin heavy-chain mutations in hypertrophic cardiomyopathy. Am J Hum Genet 1993; 53: 1180-5.
21. Dausse E, Komajda M, Fetler L, et al. Familial hypertrophic cardiomyopathy: microsatellite haplotyping and identification of a hot spot for mutations in the β-myosin heavy chain gene. J Clin Invest 1993; 92: 2807-13.
22. 719Gln, in the β-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy. Hum Mol Genet 1994; 3: 1025-6.
23. Marian AJ, Yu QT, Mares A Jr, Hill R, Roberts R, Perryman MB. Detection of a new mutation in the β-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy. J Clin Invest 1992; 90: 2156-65.
24. Epstein ND, Fananapazir L, Lin HJ, et al. Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathy. Circulation 1992; 85: 635-47.
25. Watkins H, MacRae C, Thierfelder L, et al. A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. Nat Genet 1993; 3: 333-7.
26. Thierfelder LC, MacRae C, Watkins II, et al. A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 15q2. Proc Natl Acad Sci USA 1993; 90: 6270-4.
27. Mesnard L, Samson F, Espinasse I, Durand J-B, Neveux J-Y, Mercadier JJ. Molecular cloning and developmental expression of human cardiac troponin T. FEBS Lett 1993; 328: 139-44.
28. Townsend PJ, Farza H, MacGeon C, et al. Human cardiac troponin T: identification of fetal isoforms and assignment of the TNNT2 locus to chromosome 1q. Genomics 1994; 21: 311-6.
29. Mesnard L, Logeart D, Taviaux S, Diriong S, Mercadier J, Samson F. Human cardiac troponin T: cloning and expression of new isoforms in the normal and failing heart. Circ Res 1995; 76: 687-92.
30. Anderson PAW, Geig A, Mark TM, et al. Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. Circ Res 1995; 76: 681-6.
31. Farah CS, Reinach FC. The troponin complex and regulation of muscle contraction. FASEB J 1995; 9: 755-67.
32. Watkins H, McKenna WJ, Thierfelder L, et al. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995; 332: 1058-64.
33. Forissier F-F, Carrier L, Farza H, et al. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation 1996; 94: 3069-73.
34. Zot AS, Potter JD. Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction. Annu Rev Biochem 1987; 16: 535-59.
35. Watkins H, Anan R, Coviello DA, Spirito P, Seidman JG, Seidman CE. A de novo mutation in α-tropomyosin that causes hypertrophic cardiomyopathy. Circulation 1995; 91: 2302-5.
36. Offer G, Moos C, Starr R. A new protein of the thick filaments of vertebrate skeletal myofibrils. Extraction, purification and characterization. J Mol Biol 1973; 74: 653-76.
37. Gilbert R, Kelly MG, Mikawa T, Fischman DA. A carboxy terminum of myosin binding protein C (MyBP-C) specifies incorporation into the A band of straited muscle. J Cell Sci 1996; 109: 101-11.
38. Freiberg A, Gautel M. A molecular map of the interactions between titin and myosin-binding protein C: implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Eur J Biochem 1996; 235: 317-23.
39. Carrier L, Bonne G, Bahrend E, et al. Organization and sequence of human cardiac myosin binding protein C gene (MyBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res 1997; 80: 427-34.
40. Niimura H, Bachinski LL, Sangnatanaroj S, et al. Human cardiac myosin binding protein C mutations cause late-onset familial hypertrophic cardiomyopathy. N Engl J Med 1998; 338: 1248-57.
41. Gautel M, Zuffardi O, Freiburg A, Labeit S. Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction? Embo J 1995; 14: 1952-60.
42. Rottbauer W, Gautel M, Zehlein J, et al. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization of cardiac transcript and protein. J Clin Invest 1997; 100: 475-82.
43. Lowey S, Waller GS, Trybus KM. Skeletal muscle myosin light chains are essential for physiological speeds of shortening. Nature 1993; 365: 454-6.
44. Morano M, Zacharzowski U, Maier M, et al. Regulation of human heart contractility by essential myosin light chain isoforms. J Clin Invest 1996; 98: 467-73.
45. Gulick J, Hewett TE, Klevitsky R, Buck SH, Moss RL, Robbins J. Transgenic remodeling of the regulatory light chains in the mammalian heart. Circ Res 1997; 80: 655-64.
46. Sweeney HL, Bowmann BF, Stull JT. Myosin light chain phosphorylation in vertebrate striated muscle: regulation and function. Am J Physiol 1993; 264: C1085-95
47. Tohtong R, Yamashita H, Graham M, Haeberle J, Simcox A, Maughan D. Impairment of muscle function caused by mutations of phosphorylation sites in myosin regulatory lighy chain. Nature 1995; 374: 650-3.
48. Bermingham N. Mapping TNNCI, the gene that encodes cardiac troponin I in the human and mouse. Genomics 1995; 30: 620-2.
49. Watkins H, Rosenzweig A, Hwang D, et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992; 326: 1108-14.
50. Anan R, Greve G, Thierfelder L, et al. Prognostic implications of novel β cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 1994; 93: 280-5.
51. Marian AJ, Mares A Jr, Kelly DP, et al. Sudden cardiac death in hypertrophic cardiomyopathy: variability in phenotypic expression of β-myosin heavy chain mutations. Eur Heart J 1995; 16: 368-76.
52. Epstein ND, Cohn GM, Cyran F, Fananapazir L. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the β-myosin heavy chain gene: a 908 Leu-Val mutation and a 403 Arg-Gln mutation. Circulation 1992; 86: 345-52.
53. Fananapazir L, Epstein ND. Genotype-phenotype correlations in hypertrophic cardiomyopathy: insights provided by comparisons of kindreds with distinct and identical β-myosin heavy chain gene mutations. Circulation 1994; 89: 22-32.
54. Abchee AB, Marian AJ. Prognostic significance of β-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy. J Investis Med 1997; 45: 191-6.
55. Moolman J, Corfield VA, Rosen B, et al. Sudden death due to troponin T mutations. J Am Coll Cardiol 1997; 29: 549-55.
56. Coviello DA, Maran BJ, Spirito P, et al. Clinical features of hypertrophic cardiomyopathy caused by mutations of a "hot spot" in the alpha-tropomyosin gene. J Am Coll Cardiol 1997; 29: 635-40.
57. Marian AJ, Yu QT, Workman R, Greve G, Roberts R. Angiotensin converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993; 342: 1085-6.
58. Lechin M, Yu QT, Roberts R, Quinones MA, Marian AJ. Angiotensin I converting enzyme geneotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995; 92: 1808-12.
59. Sweeney HL, Straceski AJ, Leinwand LA, Tikunov BA, Faust L. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J Biol Chem 1994; 269: 1603-5.
60. Sata M, Ikebe M. Functional analysis of the mutations in the human cardiac β-myosin that are responsible for familial hypertrophic cardiomyopathy: implication for the clinical outcome. J Clin Invest 1996; 98: 2866-73.
61. Lin D, Bobkova A, Homsher E, Tobacman LS. Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy. J Clin Invest 1996; 97: 2842-8.
62. Golitsina N, An Y, Greenfield NJ, et al. Effects of two familial hypertrophic cardiomyopathy-causing mutations on alpha-tropomyosin structure and function. Biochemistry 1997; 36: 4637-42.
63. Cuda G, Fananapazir L, Zhu W-S, Sellers JR, Epstein ND. Skeletal muscle expression and abnormal function of β myosin in hypertrophic cardiomyopathy. J Clin Invest 1993; 91: 2861-5.
64. Lankford EB, Epstein ND, Fananapazir L, Sweeney HL. Abnormal contractile properties of muscle fibers expressing β-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest 1995; 95: 1409-14.
65. Watkins H, Seidman CE, Seidman JG, Feng HS, Sweeney HL. Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action. J Clin Invest 1996; 98: 2456-61.
66. Marian AJ, Zhao G, Seta Y, Roberts R, Yu QT. Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocytes contractility. Circ Res 1997; 81: 76-85.
67. Straceski AJ, Geisterfer-Lowrance AA, Seidman CE, Seidman JG, Leinwand LA. Functional analysis of myosin missense mutations in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci USA. 1994; 91: 589-93.
68. Marian AJ, Yu QT, Mann DL, Graham FL, Roberts R. Expression of a mutation causing hypertrophic cardiomyopathy in adult feline cardiocytes disrupts sarcomere assembly in adult feline cardiac myocyres. Circ Res 1995; 77: 98-106.
69. Geisterfer-Lowrance AA, Christe M, Conner DA, et al. A mouse model of familial hypertrophic cardiomyopathy. Science 1996; 272: 731-4.
70. Vikstrom KL, Factor SM, Leinwand LA. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol Med 1996; 2: 556-67.
71. Hengstenberg C, Maisch B. Increased nuclear protooncogene expression in hypertrophic cardiomyopathy. Cardioscience 1993; 4: 15-20.
72. Derchi G, Bellone P, Chiarella F, Randazzo M, Zino V, Vecchi C. Plasma levels of atrial natriuretic peptide in hypertrophic cardiomyopathy. Am J Cardiol 1992; 70: 1502-4.
73. Hasegawa K, Fujiwara H, Doyama K, et al. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 1993; 88: 372-80.
74. Jones WK, Grupp IL, Doetschman T, et al. Ablation of the murine α myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest 1996; 98: 1906-17.